bromodeoxyuridine has been researched along with pki 166 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gilbert, RE; Kelly, DJ; Wassef, L | 1 |
| Alberta, JA; Guertin, AD; Kim, HA; Mak, KS; Zhang, DP | 1 |
2 other study(ies) available for bromodeoxyuridine and pki 166
| Article | Year |
|---|---|
Epidermal growth factor receptor inhibition attenuates early kidney enlargement in experimental diabetes.
Topics: Animals; Apoptosis; Bromodeoxyuridine; Cell Division; Cell Line; Diabetes Mellitus, Experimental; Epithelial Cells; ErbB Receptors; Glomerular Filtration Rate; Immunohistochemistry; Kidney; Kidney Glomerulus; Male; Organ Size; Proliferating Cell Nuclear Antigen; Pyrimidines; Pyrroles; Rats; Rats, Sprague-Dawley | 2004 |
Microanatomy of axon/glial signaling during Wallerian degeneration.
Topics: Analysis of Variance; Animals; Axotomy; Blotting, Western; Bromodeoxyuridine; Cell Proliferation; Cells, Cultured; Coculture Techniques; Demyelinating Diseases; Disease Models, Animal; Embryo, Mammalian; Female; Fluorescent Antibody Technique; Ganglia, Spinal; Gene Expression; Glycoproteins; Immunoprecipitation; Mitogen-Activated Protein Kinase Kinases; Myelin Basic Protein; Myelin Sheath; Neuregulins; Neuroglia; Neurons; Platelet-Derived Growth Factor; Pyrimidines; Pyrroles; Rats; Rats, Sprague-Dawley; Receptor Protein-Tyrosine Kinases; Receptor, ErbB-2; Schwann Cells; Sciatic Neuropathy; Signal Transduction; Sodium Channels; Time Factors; Wallerian Degeneration | 2005 |